1. Home
  2. NSPR vs FNGR Comparison

NSPR vs FNGR Comparison

Compare NSPR & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • FNGR
  • Stock Information
  • Founded
  • NSPR 2005
  • FNGR 2016
  • Country
  • NSPR Israel
  • FNGR Singapore
  • Employees
  • NSPR N/A
  • FNGR N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • NSPR Health Care
  • FNGR Technology
  • Exchange
  • NSPR Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • NSPR 63.0M
  • FNGR 74.3M
  • IPO Year
  • NSPR N/A
  • FNGR N/A
  • Fundamental
  • Price
  • NSPR $3.19
  • FNGR $1.37
  • Analyst Decision
  • NSPR Strong Buy
  • FNGR
  • Analyst Count
  • NSPR 2
  • FNGR 0
  • Target Price
  • NSPR $4.75
  • FNGR N/A
  • AVG Volume (30 Days)
  • NSPR 50.3K
  • FNGR 251.6K
  • Earning Date
  • NSPR 03-05-2025
  • FNGR 01-14-2025
  • Dividend Yield
  • NSPR N/A
  • FNGR N/A
  • EPS Growth
  • NSPR N/A
  • FNGR N/A
  • EPS
  • NSPR N/A
  • FNGR N/A
  • Revenue
  • NSPR $6,821,000.00
  • FNGR $33,570,107.00
  • Revenue This Year
  • NSPR $13.36
  • FNGR $260.03
  • Revenue Next Year
  • NSPR $49.64
  • FNGR N/A
  • P/E Ratio
  • NSPR N/A
  • FNGR N/A
  • Revenue Growth
  • NSPR 24.70
  • FNGR N/A
  • 52 Week Low
  • NSPR $1.81
  • FNGR $1.03
  • 52 Week High
  • NSPR $3.42
  • FNGR $3.96
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 63.51
  • FNGR 57.63
  • Support Level
  • NSPR $2.60
  • FNGR $1.12
  • Resistance Level
  • NSPR $3.11
  • FNGR $1.38
  • Average True Range (ATR)
  • NSPR 0.28
  • FNGR 0.09
  • MACD
  • NSPR 0.05
  • FNGR 0.02
  • Stochastic Oscillator
  • NSPR 87.15
  • FNGR 92.59

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: